arrow
Back
K

Kim Chi

University of British Columbia

26H-index
125Paper Count
3.4KCitation Count
Published Papers 29
Publication Date
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma(vol 14, 8603, 2024)
err2025-04-28
err0
errOAAI
errSoleimani, Maryam; Thi, Marisa; Janfaza, Sajjad; Ozcan, Gizem; Mazurek, Sylwia; Ozgun, Guliz; Maurice-Dror, Corinne; Eigl, Bernhard; Chi, Kim; Kollmannsberger, Christian; Nappi, Lucia
errShare
errSave
Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562]
err2025-04-08
err0
errOAAI
errAndrew J. Armstrong; Oliver Sartor; Johann de Bono; Kim Chi; Karim Fizazi; Bernd J. Krause; Ken Herrmann; Kambiz Rahbar; Scott T. Tagawa; Fred Saad; Tomasz M. Beer; Jiwen Wu; Osvaldo Mirante; Michael J. Morris
errShare
errSave
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial
err2024-12-01
err0
errOAAI
errArmstrong, Andrew J.; Sartor, Oliver; de Bono, Johann; Chi, Kim; Fizazi, Karim; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Saad, Fred; Beer, Tomasz M.; Wu, Jiwen; Mirante, Osvaldo; Morris, Michael J.
errShare
errSave
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
err2024-09-01
err1
PREAI
errRoubaud, Guilhem; Attard, Gerhardt; Boegemann, Martin; Olmos, David; Trevisan, Marco; Antoni, Laurent; Pascoe, Katie; Capone, Camille; Van Sanden, Suzy; Hashim, Mahmoud; Palmer, Stephen; Chi, Kim
errShare
errSave
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
err2024-06-28
err6
errOAAI
errMerseburger, Axel S.; Agarwal, Neeraj; Bjartell, Anders; Uemura, Hirotsugu; Soto, Alvaro Juarez; Bhaumik, Amitabha; Boehm, Juergen; Tran, Nguyen; Krochmann, Nils; Nematian-Samani, Mehregan; Mundle, Suneel D.; Brookman-May, Sabine D.; Lopez-Gitlitz, Angela; McCarthy, Sharon A.; Chi, Kim; Chowdhury, Simon
errShare
errSave
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
err2024-04-13
err1
errOAAI
errSoleimani, Maryam; Thi, Marisa; Janfaza, Sajjad; Ozcan, Gizem; Mazurek, Sylwia; Ozgun, Guliz; Maurice-Dror, Corinne; Eigl, Bernhard; Chi, Kim; Kollmannsberger, Christian; Nappi, Lucia
errShare
errSave
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
err2021-03-01
err1
PREAI
errHadaschik, Boris A.; Giesel, Frederik L.; Chi, Kim
errShare
errSave
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors
err2021-01-01
err44
PREAI
errNappi, Lucia; Thi, Marisa; Adra, Nabil; Hamilton, Robert J.; Leao, Ricardo; Lavoie, Jean-Michel; Soleimani, Maryam; Eigl, Bernhard J.; Chi, Kim; Gleave, Martin; So, Alan; Black, Peter C.; Bell, Robert; Daneshmand, Siamak; Cary, Clint; Masterson, Timothy; Einhorn, Lawrence; Nichols, Craig; Kollmannsberger, Christian
errShare
errSave
Biallelic alterations in BRCA2, ATM, or CDK12 in metastatic prostate cancer via circulating tumor DNA
err2020-08-15
err0
PREAI
errWarner, Evan; Yip, Steven; Annala, Matti; Murtha, Andrew; Herberts, Cameron; Chi, Kim; Wyatt, Alexander
errShare
errSave
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
err2019-04-12
err82
errOAAI
errRousseau, Etienne; Wilson, Don; Lacroix-Poisson, Frederic; Krauze, Andra; Chi, Kim; Gleave, Martin; McKenzie, Michael; Tyldesley, Scott; Goldenberg, S. Larry; Benard, Francxois
errShare
errSave
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
err2019-02-25
err81
errOAAI
errNickols, Nicholas G.; Nazarian, Ramin; Zhao, Shuang G.; Tan, Victor; Uzunangelov, Vladislav; Xia, Zheng; Baertsch, Robert; Neeman, Elad; Gao, Allen C.; Thomas, George, V; Howard, Lauren; De Hoedt, Amanda M.; Stuart, Josh; Goldstein, Theodore; Chi, Kim; Gleave, Martin E.; Graff, Julie N.; Beer, Tomasz M.; Drake, Justin M.; Evans, Christopher P.; Aggarwal, Rahul; Foye, Adam; Feng, Felix Y.; Small, Eric J.; Aronson, William J.; Freedland, Stephen J.; Witte, Owen N.; Huang, Jiaoti; Alumkal, Joshi J.; Reiter, Robert E.; Retti, Matthew B.
errShare
errSave
DETECTION OF ANDROGEN RECEPTOR VARIANT 7 (AR-V7) IN WHOLE BLOOD RNA OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS TREATED WITH ABIRATERONE ACETATE (ABI)
err2016-04-01
err0
errOAAI
errTodenhoefer, Tilman; Azad, Arun; Gao, Jian; Stewart, Craig; Eigl, Bernie; Stenzl, Arnulf; Teich, Miriam; Black, Peter; Joshua, Anthony; Chi, Kim
errShare
errSave
NOVEL COMBINATION TREATMENT (OGX427/ SORAFENIB) ENHANCES SENSITIVITY IN RENAL CELL CARCINOMA
err2016-04-01
err0
errOAAI
errFrees, Sebastian; Chavez-Munoz, Claudia; Raven, Peter; Zhou, Betty; Gleave, Martin; Chi, Kim; So, Alan
errShare
errSave
SECOND-GENERATION ANTISENSE OLIGONUCLEOTIDE-HSP27 A NEW INTRAVESICAL TREATMENT FOR BLADDER CANCER: PHASE 1CLINICAL TRIAL.
err2016-04-01
err0
errOAAI
errFrees, Sebastian; Beraldi, Eliana; Chi, Kim; Fazli, Ladan; Black, Peter; Gleave, Martin; So, Alan
errShare
errSave
errShare
errSave
Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
err2013-05-12
err180
errOAAI
errShiota, Masaki; Bishop, Jennifer L.; Nip, Ka Mun; Zardan, Anousheh; Takeuchi, Ario; Cordonnier, Thomas; Beraldi, Eliana; Bazov, Jenny; Fazli, Ladan; Chi, Kim; Gleave, Martin; Zoubeidi, Amina
errShare
errSave
Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c
err2011-09-01
err117
errOAAI
errSaad, Fred; Hotte, Sebastien; North, Scott; Eigl, Bernie; Chi, Kim; Czaykowski, Piotr; Wood, Lori; Pollak, Michael; Berry, Scott; Lattouf, Jean-Baptiste; Mukherjee, Som D.; Gleave, Martin; Winquist, Eric
errShare
errSave
ABERRANT SONIC HEDGEHOG SIGNALING IN RENAL CELL CARCINOMA
err2010-04-01
err0
PREAI
errGust, Kilian M.; Fazli, Ladan; Li, Estelle; Awrey, Shannon; Kollmannsberger, Christian; Chi, Kim; Black, Peter C.
errShare
errSave